Project Number 5P50AG016574-12 Agency/Funding Organization NIA Funding Year 2010 View Full Project Details for IDENTIFYING MULTI-MODALITY IMAGING CORRELATES OF DEMENTIA WITH LEWY BODIES AND AD Research Categorization Primary Disease / Condition Alzheimer's Disease Lewy Body Dementias CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 2. Imaging Biomarkers j. Multiple Imaging Category F. Research Resources 1. Alzheimer's Disease Centers Researcher and Organization Principal Investigator KANTARCI, KEJAL Principal Investigator First Name KEJAL Principal Investigator Last Name KANTARCI Awardee Organization MAYO CLINIC ROCHESTER Awardee State Minnesota Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-09-001: ALZHEIMER'S DISEASE RESEARCH CENTERS (P50) FY Overall Cost $157,470 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PHELPS, CREIGHTON H. Related Resources Repository National Alzheimer's Coordinating Center (NACC) National Alzheimer's Coordinating Center (NACC) [AlzPED] Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice. [AlzPED] Intracranial Adeno-Associated Virus-Mediated Delivery of Anti-Pan Amyloid β, Amyloid β40, and Amyloid β42 Single-Chain Variable Fragments Attenuates Plaque Pathology in Amyloid Precursor Protein Mice Clinical Trial Tau PET Imaging in African Americans ''Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies'' Pagination Previous page ‹‹ Page 2
